Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 4, Pages 877
Publisher
MDPI AG
Online
2020-04-07
DOI
10.3390/cancers12040877
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-PD-L1 treatment results in functional remodeling of the macrophage compartment
- (2019) Huizhong Xiong et al. CANCER RESEARCH
- Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
- (2018) Frank Vari et al. BLOOD
- PD-L1+ tumor-associated macrophages and PD-1+ tumor infiltrating lymphocytes predict survival in primary testicular lymphoma
- (2018) Marjukka Pollari et al. HAEMATOLOGICA
- PD-L1+ tumor-associated macrophages and PD-1+ tumor infiltrating lymphocytes predict survival in primary testicular lymphoma
- (2018) Marjukka Pollari et al. HAEMATOLOGICA
- The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
- (2018) Nicholas Meti et al. Cancers
- T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma
- (2018) Suvi-Katri Leivonen et al. HAEMATOLOGICA
- Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers
- (2018) Takefumi Komiya et al. Frontiers in Oncology
- IDO1: An important immunotherapy target in cancer treatment
- (2017) Fangxuan Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
- (2017) Robert Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Checkpoint Inhibition in Hodgkin Lymphoma - a Review
- (2017) Paul J. Bröckelmann et al. Oncology Research and Treatment
- Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
- (2016) Baoping Guo et al. BMC Medicine
- Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance
- (2016) Donatella Aldinucci et al. CANCER LETTERS
- The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints
- (2016) S. Vardhana et al. HAEMATOLOGICA
- Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma
- (2016) Manuel Gotti et al. HEMATOLOGICAL ONCOLOGY
- Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure
- (2016) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
- (2016) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
- (2016) Anas Younes et al. LANCET ONCOLOGY
- The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints
- (2016) S. Vardhana et al. HAEMATOLOGICA
- Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment
- (2015) Emanuele Cencini et al. HEMATOLOGICAL ONCOLOGY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma
- (2015) Young Wha Koh et al. TUMOR BIOLOGY
- Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study
- (2014) Ji-Young Choe et al. BMC CANCER
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
- (2014) George C. Prendergast et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Programmed death-1 pathway in cancer and autoimmunity
- (2014) Ariel Pedoeem et al. CLINICAL IMMUNOLOGY
- CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma
- (2014) Young Wha Koh et al. PLoS One
- The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling
- (2014) D. W. Scott et al. Hematology-American Society of Hematology Education Program
- CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma
- (2013) Smita Kayal et al. LEUKEMIA & LYMPHOMA
- Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial
- (2012) K. L. Tan et al. BLOOD
- Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma
- (2012) B. Sanchez-Espiridion et al. HAEMATOLOGICA
- Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma
- (2011) D. Azambuja et al. ANNALS OF ONCOLOGY
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
- (2011) Christian Steidl et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
- (2010) P. Kamper et al. HAEMATOLOGICA
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started